The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
Hosted on MSN2mon
EMA Accepts GSK's Filing for Depemokimab in Two Respiratory DiseasesConcerning CRSwNP, GSK intends to secure approval in adults. Similar regulatory filings for the drug have also been validated for review in China and Japan. If approved, depemokimab will be the ...
Hosted on MSN3mon
GSK's belantamab mafodotin reduced death risk by 42% in studyGSK (NYSE:GSK) reported that a study showed its ... been accepted by regulators in the United States, European Union, Japan, China, United Kingdom, Canada and Switzerland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results